BADRIA ADAMO: Open Payments
NPI 1144989989 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,578 in 62 payments from 16 companies in 2025. Trend: 2023 $449 · 2024 $458 · 2025 $1,578
Food & beverage: $1,578
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $276 |
| Novartis Pharmaceuticals Corporation | 11 | $214 |
| Novo Nordisk Inc | 4 | $183 |
| Edwards Lifesciences Corporation | 2 | $164 |
| AstraZeneca Pharmaceuticals LP | 5 | $147 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $137 |
| SCPHARMACEUTICALS INC. | 5 | $118 |
| Amgen Inc. | 4 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $64 |
| E.R. Squibb & Sons, L.L.C. | 4 | $59 |
Products named: VYNDAQEL, LEQVIO, Wegovy, LifeVest, FARXIGA, FUROSCIX, Repatha, Kerendia.
Industry payments across FL — which companies pay providers there.
